ORIENT-12
Regimen
- Experimental
- sintilimab + gemcitabine + platinum
- Control
- placebo + gem + platinum
Population
Chinese 1L sq NSCLC
Key finding
mPFS 5.5 vs 4.9 mo, HR 0.536 (0.422-0.681); sintilimab 1L sq
Source: PMID 34048947
Timeline
Guideline citations
- CSCO NSCLC 2025 ⚠️ OCR source